280 related articles for article (PubMed ID: 28728838)
21. Clinical study of 19 patients with SCN8A-related epilepsy: Two modes of onset regarding EEG and seizures.
Denis J; Villeneuve N; Cacciagli P; Mignon-Ravix C; Lacoste C; Lefranc J; Napuri S; Damaj L; Villega F; Pedespan JM; Moutton S; Mignot C; Doummar D; Lion-François L; Gataullina S; Dulac O; Martin M; Gueden S; Lesca G; Julia S; Cances C; Journel H; Altuzarra C; Ben Zeev B; Afenjar A; Barth M; Villard L; Milh M
Epilepsia; 2019 May; 60(5):845-856. PubMed ID: 31026061
[TBL] [Abstract][Full Text] [Related]
22. A novel de novo KCNQ2 mutation in a child with treatmentresistant early-onset epileptic encephalopathy.
Benetou C; Papailiou S; Maritsi D; Anagnostopoulou K; Kontos H; Vartzelis G
Turk J Pediatr; 2019; 61(2):279-281. PubMed ID: 31951342
[TBL] [Abstract][Full Text] [Related]
23. Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2.
Dedek K; Fusco L; Teloy N; Steinlein OK
Epilepsy Res; 2003 Apr; 54(1):21-7. PubMed ID: 12742592
[TBL] [Abstract][Full Text] [Related]
24. Vitamin B6-Responsive Epilepsy due to a Novel KCNQ2 Mutation.
Klotz KA; Lemke JR; Korinthenberg R; Jacobs J
Neuropediatrics; 2017 Jun; 48(3):199-204. PubMed ID: 28420012
[TBL] [Abstract][Full Text] [Related]
25. Variable expressivity of a likely pathogenic variant in KCNQ2 in a three-generation pedigree presenting with intellectual disability with childhood onset seizures.
Hewson S; Puka K; Mercimek-Mahmutoglu S
Am J Med Genet A; 2017 Aug; 173(8):2226-2230. PubMed ID: 28602030
[TBL] [Abstract][Full Text] [Related]
26. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.
Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J
Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921
[TBL] [Abstract][Full Text] [Related]
27. Nine patients with KCNQ2-related neonatal seizures and functional studies of two missense variants.
Chokvithaya S; Caengprasath N; Buasong A; Jantasuwan S; Santawong K; Leela-Adisorn N; Tongkobpetch S; Ittiwut C; Saengow VE; Kamolvisit W; Boonsimma P; Bongsebandhu-Phubhakdi S; Shotelersuk V
Sci Rep; 2023 Feb; 13(1):3328. PubMed ID: 36849527
[TBL] [Abstract][Full Text] [Related]
28. A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.
Milh M; Roubertoux P; Biba N; Chavany J; Spiga Ghata A; Fulachier C; Collins SC; Wagner C; Roux JC; Yalcin B; Félix MS; Molinari F; Lenck-Santini PP; Villard L
Epilepsia; 2020 May; 61(5):868-878. PubMed ID: 32239694
[TBL] [Abstract][Full Text] [Related]
29. Effect of total callosotomy on KCNQ2-related intractable epilepsy.
Yamamoto A; Saito Y; Oyama Y; Watanabe Y; Ikeda A; Takayama R; Ikeda H; Takeshita S; Takumi I; Itai T; Miyatake S; Matsumoto N
Brain Dev; 2020 Sep; 42(8):612-616. PubMed ID: 32532640
[TBL] [Abstract][Full Text] [Related]
30. The variable phenotypes of KCNQ-related epilepsy.
Allen NM; Mannion M; Conroy J; Lynch SA; Shahwan A; Lynch B; King MD
Epilepsia; 2014 Sep; 55(9):e99-105. PubMed ID: 25052858
[TBL] [Abstract][Full Text] [Related]
31. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
[TBL] [Abstract][Full Text] [Related]
32. Pointed rhythmic theta waves: a unique EEG pattern in KCNQ2-related neonatal epileptic encephalopathy.
Buttle SG; Sell E; Dyment D; Bulusu S; Pohl D
Epileptic Disord; 2017 Sep; 19(3):351-356. PubMed ID: 28832002
[TBL] [Abstract][Full Text] [Related]
33. Deletions or duplications in KCNQ2 can cause benign familial neonatal seizures.
Heron SE; Cox K; Grinton BE; Zuberi SM; Kivity S; Afawi Z; Straussberg R; Berkovic SF; Scheffer IE; Mulley JC
J Med Genet; 2007 Dec; 44(12):791-6. PubMed ID: 17675531
[TBL] [Abstract][Full Text] [Related]
34. Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
Kuersten M; Tacke M; Gerstl L; Hoelz H; Stülpnagel CV; Borggraefe I
Eur J Med Genet; 2020 Jan; 63(1):103628. PubMed ID: 30771507
[TBL] [Abstract][Full Text] [Related]
35. Video/EEG findings in a KCNQ2 epileptic encephalopathy: a case report and revision of literature data.
Serino D; Specchio N; Pontrelli G; Vigevano F; Fusco L
Epileptic Disord; 2013 Jun; 15(2):158-65. PubMed ID: 23774309
[TBL] [Abstract][Full Text] [Related]
36. A novel
Liu HF; Yuan TY; Yang JW; Li F; Wang F; Fu HM
Mol Med Rep; 2022 Sep; 26(3):. PubMed ID: 35856407
[TBL] [Abstract][Full Text] [Related]
37. KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.
Neubauer BA; Waldegger S; Heinzinger J; Hahn A; Kurlemann G; Fiedler B; Eberhard F; Muhle H; Stephani U; Garkisch S; Eeg-Olofsson O; Müller U; Sander T
Neurology; 2008 Jul; 71(3):177-83. PubMed ID: 18625963
[TBL] [Abstract][Full Text] [Related]
38. Clinical and genetic analysis of 18 patients with
Cao B; Peng B; Tian Y; Wang X; Li X; Zhu H; Shen H; Chen W
Turk J Pediatr; 2024 May; 66(2):191-204. PubMed ID: 38814296
[TBL] [Abstract][Full Text] [Related]
39. Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy.
Soldovieri MV; Freri E; Ambrosino P; Rivolta I; Mosca I; Binda A; Murano C; Ragona F; Canafoglia L; Vannicola C; Solazzi R; Granata T; Castellotti B; Messina G; Gellera C; Labalme A; Lesca G; DiFrancesco JC; Taglialatela M
Pharmacol Res; 2020 Oct; 160():105200. PubMed ID: 32942014
[TBL] [Abstract][Full Text] [Related]
40. Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate.
Soldovieri MV; Ambrosino P; Mosca I; De Maria M; Moretto E; Miceli F; Alaimo A; Iraci N; Manocchio L; Medoro A; Passafaro M; Taglialatela M
Sci Rep; 2016 Dec; 6():38167. PubMed ID: 27905566
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
